Carol Cornman, Vice President of the Childhood Brain Tumor Foundation, lends her leadership skills to the organization. Each year family, friends, and supporters join Carol and her daughters in celebrating the memory of her husband Geoff Cornman, a victim of a brain tumor many years ago. Carol graduated from the Penn State University with a …
President and Founding Member of CBTF Mrs. Young is the President and one of the Founding members of the Childhood Brain Tumor Foundation, an all-volunteer nonprofit organization founded in 1994 dedicated to supporting research, heightening awareness, and improving the quality of life for children affected by brain tumors. Her dedication to the cause comes from …
Experts of varying disciplines will present families with helpful information and updates about childhood brain tumors. This event was cancelled due to COVID-19.
Did you participate in our Virtual 5k race? Please upload your photos to our race gallery today: CBTF 2020 Superheroes 5k Race Gallery upload page There will be a photo competition for the most liked/loved photos that participants post on our special 5K Facebook page: 5KFacebookPage Link Sharing photos will be a fun way to see some of …
Professor PediatricsDirector and Aflac Chair, Pediatric Neuro-Oncology Program, Children’s Healthcare of Atlanta, Emory University School of Medicine Following his training in pediatrics, pediatric hematology-oncology and neuro-oncology all at Children’s Hospital of Los Angeles, Dr. MacDonald continued to build an academic career that encompasses the clinical, basic and translational research of childhood brain tumors. His work …
Surgical Theater, the market leader in virtual and augmented reality healthcare services, is the first to combine fighter jet flight simulation technology with a patient’s own anatomy scans. Rendered from CT, MRI, and advanced post processing images such as DTI, BOLD and Perfusion, the 360° virtual reality model is designed to allow surgeons and patients …
CBTF Sponsors and Partnerships Sponsors Partners
Abstract: CD133+ subpopulations of cells in glioblastoma (GBM) show in vivo resistance to treatment with radiation and temozolomide, and are thought to contribute to therapy evasion and tumor recurrence. Frequent hyperactivation of the MAPK pathway in GBM has prompted the clinical evaluation of several pharmacological MAPK pathway inhibitors for the treatment of GBM. Here we …
by Tobey MacDonald, M.D., Children’s Healthcare of Atlanta and Emory University School of Medicine, Atlanta, GA In 1971, Dr. Judah Folkman, then surgeon-in-chief of Children’s Hospital Boston, reported in the New England Journal of Medicine that solid tumors are dependent on “angiogenesis”, the formation of new blood vessels, for survival and growth. He proposed that …
